Technical Analysis for NVS - Novartis AG

Grade Last Price % Change Price Change
B 92.39 -0.79% -0.74
NVS closed down 0.79 percent on Wednesday, June 23, 2021, on approximately normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down
Historical NVS trend table...

Date Alert Name Type % Chg
Cup with Handle Other 0.00%
Outside Day Range Expansion 0.00%
Cup with Handle Other -0.79%
Narrow Range Bar Range Contraction -0.79%
NR7 Range Contraction -0.79%
Overbought Stochastic Strength -0.79%
Overbought Stochastic Strength -1.62%
Overbought Stochastic Strength -0.67%
180 Bullish Setup Bullish Swing Setup -1.87%
Slingshot Bullish Bullish Swing Setup -1.87%
Older End-of-Day Signals for NVS ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakdown about 18 hours ago
Outside Day about 19 hours ago
Fell Below Previous Day's Low about 19 hours ago
Gap Up Closed about 19 hours ago
1.5x Volume Pace about 19 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Novartis AG Description

Novartis AG engages in the research, development, manufacture, and marketing of a range of healthcare products worldwide. Its Pharmaceuticals division offers patented prescription medicines in various therapeutic areas, including oncology; primary care and established medicines; specialty care, such as ophthalmology, neuroscience, integrated hospital care, and critical care; and cardiovascular and metabolism, respiratory, and other medicines. The company's Alcon division provides various eye care products, including ophthalmic surgical equipment, instruments, disposable products, and intraocular lenses; medicines to treat chronic and acute diseases of the eye; over-the-counter medicines for the eye; and contact lenses and lens care products. Its Sandoz division offers prescription medicines, as well as pharmaceutical and biotechnological active substances. This division provides active ingredients and finished dosage forms of pharmaceuticals; active pharmaceutical ingredients and intermediates, primarily antibiotics; protein or biotechnology-based products; cytotoxic products for the hospital market; and biotech manufacturing services to other companies. The company's Vaccines and Diagnostics division provides preventive human vaccines, and blood testing and molecular diagnostics products to prevent the spread of infectious diseases. Its Consumer Health division consists of two divisions, including over-the-counter medicines that offer readily available consumer medicines; and Animal Health, which provides veterinary products for farm and companion animals. Novartis AG was founded in 1895 and is headquartered in Basel, Switzerland.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: Biotechnology Pharmaceutical Industry Eye Drugs Infectious Diseases Pharmaceuticals Pharmacy Medication Neuroscience Animal Health Antibiotic Ophthalmic Ophthalmology Eyewear Dosage Forms Healthcare Products Healthcare Product Prescription Drug Metabolism Disposable Products Lenses Molecular Diagnostics Active Pharmaceutical Ingredients Disposable Product Antibiotics Primary Care Blood Test Contact Lens Contact Lenses Eye Care Over The Counter Drug Surgical Equipment Diagnostics Products Intraocular Lens Lens Care Products Veterinary Products

Is NVS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 98.52
52 Week Low 77.04
Average Volume 1,830,307
200-Day Moving Average 88.62
50-Day Moving Average 89.11
20-Day Moving Average 91.39
10-Day Moving Average 93.41
Average True Range 1.01
ADX 35.58
+DI 32.33
-DI 15.85
Chandelier Exit (Long, 3 ATRs) 91.73
Chandelier Exit (Short, 3 ATRs) 90.96
Upper Bollinger Bands 95.78
Lower Bollinger Band 87.00
Percent B (%b) 0.61
BandWidth 9.62
MACD Line 1.38
MACD Signal Line 1.37
MACD Histogram 0.0131
Fundamentals Value
Market Cap 210.14 Billion
Num Shares 2.27 Billion
EPS 3.09
Price-to-Earnings (P/E) Ratio 29.93
Price-to-Sales 4.14
Price-to-Book 3.72
PEG Ratio 2.78
Dividend 3.09
Dividend Yield 3.34%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 94.37
Resistance 3 (R3) 94.59 94.15 94.04
Resistance 2 (R2) 94.15 93.65 94.04 93.93
Resistance 1 (R1) 93.27 93.33 93.05 93.05 93.82
Pivot Point 92.83 92.83 92.72 92.72 92.83
Support 1 (S1) 91.95 92.33 91.73 91.73 90.96
Support 2 (S2) 91.51 92.01 91.40 90.85
Support 3 (S3) 90.63 91.51 90.74
Support 4 (S4) 90.41